People/ivan-vrkic
Ivan Vrkic

Ivan Vrkic

co-founderYC

Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.

linkedin
1
product
Products · 1
CellType
Co-Founder

CellType offers a model to improve drug development through biological response predictions.

Worked alongside
David van Dijk
Roles are derived from products, launches and repositories we track — not from self-description.